VaxLiant gets go ahead for new adjuvants; China vet med manufacturer sinks in $5M;

> In Iowa, the country's largest pork producer, there have been more reported cases of positive porcine epidemic diarrhea (PEDv) tests than in any other of the 31 states where the swine-killing infection has spread. More

> VaxLiant had 6 of its vaccine adjuvants approved by the USDA for the treatment of swine and cattle. Release

> China-based manufacturer of vet meds, vaccines and feed additives, Skystar Bio-Pharmaceutical, announced a $5 million registered direct offering. Item

> Keego Harbor, MI-based Health Enhancement Products secured enough capital to fund testing for its product aimed to treat bovine mastitis. Release

> Grazix Animal Health joined the Minnesota biotechnology center and will focus on natural animal health products it says are based off reactive plant immunity. Article

> A market research report said that both companion and production animals are giving the industry enough steam to reach about $42 million by 2019. Report

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…